MedTrace Logo

Effect of Age on the Median Effective Dose(ED50) for Motor Block With Intrathecal Ropivacaine

NCT02102607 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2015-10-27

No results posted yet for this study

Summary

The primary aim of this study was to determine the median effective dose (ED50) for motor block of intrathecally-administered ropivacaine in adults (20-80 years), and to assess the effect of age on ED50 required for motor block.

Conditions

  • Anesthesia

Interventions

OTHER

age

subjects stratified according to age: 20-30 years (Group 1), 31-40 years (Group 2), 41-50 years (Group 3), 51-60 years (Group 4), 61-70 years (Group 5), and 71-80 years (Group 6).

Sponsors & Collaborators

  • China Three Gorges University, Yichang, China

    lead OTHER

Principal Investigators

  • jun yang, PhD · China Three Gorges University

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-03-31
Completion
2015-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02102607 on ClinicalTrials.gov